| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunityBio, Inc. | Director | Stock Option (right to buy) | 162,786 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 18:34 |
| BACC | Blue Acquisition Corp/Cayman | 12 Jun 2025 | 0 | $0 | 3 | Director | 12 Jun 2025, 20:03 |
| IBRX | ImmunityBio, Inc. | 11 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 18:49 |
| IBRX | ImmunityBio, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:27 |
| IBRX | ImmunityBio, Inc. | 01 Jun 2023 | 1 | $20,370 | 4 | Director | 05 Jun 2023, 19:54 |
| IBRX | ImmunityBio, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 21:20 |
| IBRX | ImmunityBio, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 18:33 |
| IBRX | ImmunityBio, Inc. | 09 Mar 2021 | 0 | $0 | 3/A | Director | 01 Mar 2023, 19:43 |